Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 8—August 2007
Research

Risk Factors for Colonization with Extended-Spectrum β-Lactamase–producing Bacteria and Intensive Care Unit Admission

Anthony D. Harris*†Comments to Author , Jessina C. McGregor*, Judith A. Johnson*†, Sandra M. Strauss*, Anita C. Moore*, Harold C. Standiford‡, Joan N. Hebden‡, and J. Glenn Morris*
Author affiliations: *University of Maryland, Baltimore, Maryland, USA; †Veterans Affairs Maryland Health Care System, Baltimore, Maryland, USA; ‡University of Maryland Medical Center, Baltimore, Maryland, USA;

Main Article

Table 3

History of culture positivity with antimicrobial drug–resistant bacteria among 117 patients colonized with ESBL-producing bacteria at ICU admission*

Drug-resistant bacteriaNo. ESBL colonized (%)
ESBL-positive clinical cultures before ICU admission†6 (5)
ESBL-positive clinical cultures after colonization29 (25)
Methicillin-resistant Staphylococcus aureus†25 (21)
Vancomycin-resistant enterococci‡27 (23)

*ESBL, extended-spectrum β-lactamase; ICU, intensive care unit.
†Positive clinical cultures during the same hospital admission but before ICU admission.
‡Clinical or surveillance cultures at any time before ICU admission.

Main Article

Page created: June 30, 2010
Page updated: June 30, 2010
Page reviewed: June 30, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external